Double Dhamaka! Board Announces 10:1 Stock Split & 4:10 Bonus Shares: Debt-Free Penny Stock Under Rs 75 Rockets Over 9 Per Cent

Double Dhamaka! Board Announces 10:1 Stock Split & 4:10 Bonus Shares: Debt-Free Penny Stock Under Rs 75 Rockets Over 9 Per Cent

The stock is up by 76.50 per cent from its 52-week low of Rs 40.23 per share and gave multibagger returns of 500 per cent in 2 years.

On Friday, one of the Top Gainers on BSE, shares of Achyut Healthcare Ltd rocketed over 9 per cent to Rs 71 per share from its previous closing of Rs 65. The stock’s 52-week high is Rs 71.90 and its 52-week low is Rs 40.23.

The Board of Directors of the Company has approved the following proposals: 1) The subdivision of each existing equity share with a face value of Rs 10 into ten equity shares with a face value of Re 1 each, subject to shareholder approval. 2) A bonus issue in the ratio of 4:10, meaning that for every ten existing fully paid-up equity shares with a face value of Re 1 each, four new bonus equity shares with a face value of Re. 1 each will be issued. These proposals are intended to increase the liquidity of the Company's shares and enhance shareholder value. The record date for bonus shares and stock split is not yet fixed.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

About the Company

Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, pharmaceutical products, medical devices, etc. The company is also in the manufacturing of pharmaceutical formulations in the forms of tablets, capsules, oral liquids and injectables.

Achyut Healthcare, an SME stock, has a market cap of Rs 111.50 crore and as of June 2024, the company is debt-free. The stock is up by 76.50 per cent from its 52-week low of Rs 40.23 per share and gave multibagger returns of 500 per cent in 2 years. Investors should keep an eye on this penny stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

Also Read: This solar PV manufacturer could illuminate the primary market; can it double your investment?

Rate this article:
3.2

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary18-Oct, 2024

Penny Stocks20-Oct, 2024

Multibaggers20-Oct, 2024

Penny Stocks20-Oct, 2024

Penny Stocks20-Oct, 2024

Knowledge

Personal Finance16-Oct, 2024

MF16-Oct, 2024

Technical14-Oct, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR